Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
暂无分享,去创建一个
[1] Krishnendu Roy,et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.
[2] K. Kusumoto,et al. Prefabricated muscle flap including bone induced by recombinant human bone morphogenetic protein-2: an experimental study of ectopic osteoinduction in a rat latissimus dorsi muscle flap. , 1998, British journal of plastic surgery.
[3] Timothy E. Long,et al. Electrospinning of linear homopolymers of poly(methyl methacrylate): exploring relationships between fiber formation, viscosity, molecular weight and concentration in a good solvent , 2005 .
[4] Yasuhiko Tabata,et al. Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. , 2006, Biomaterials.
[5] P. Boyne,et al. Application of Bone Morphogenetic Proteins in the Treatment of Clinical Oral and Maxillofacial Osseous Defects , 2001, The Journal of bone and joint surgery. American volume.
[6] K. Takaoka,et al. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. , 2005, Advanced drug delivery reviews.
[7] R. Müller,et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy , 2001, The journal of gene medicine.
[8] K. Leong,et al. DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[9] M. Heidaran,et al. Molecular Signaling in Bioengineered Tissue Microenvironments , 2002, Annals of the New York Academy of Sciences.
[10] J. Lou,et al. Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[11] R. Mumper,et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[12] A Daluiski,et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. , 1999, The Journal of bone and joint surgery. American volume.
[13] Y Wang,et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[14] K. Kusumoto,et al. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. , 1995, Biochemical and biophysical research communications.
[15] David L Kaplan,et al. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. , 2006, Biomaterials.
[16] Chi-Hwa Wang,et al. Self-Assembled Biodegradable Nanoparticles Developed by Direct Dialysis for the Delivery of Paclitaxel , 2005, Pharmaceutical Research.
[17] K. Leong,et al. DNA-Chitosan nanospheres for gene delivery , 1996 .
[18] Luigi Lazzeri,et al. Biodegradable hollow microfibres to produce bioactive scaffolds , 2005 .
[19] K. Kusumoto,et al. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. , 2000, International journal of oral and maxillofacial surgery.